Impact of Second-Line Treatment on Overall Survival of Advanced Lung Adenocarcinoma Patients

doi 10.1183/13993003.congress-2016.pa4840
Full Text
Abstract

Available in full text

Date
Authors
Publisher

European Respiratory Society

Related search

Docetaxel Monotherapy as Second-Line Treatment for Pretreated Advanced Non-Small Cell Lung Cancer Patients

Korean Journal of Internal Medicine
Internal Medicine
2007English

P026 Impact of Prior Cancer History on the Overall Survival of Younger Patients With Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Iron Accumulation in Tumor-Associated Macrophages Marks an Improved Overall Survival in Patients With Lung Adenocarcinoma

Scientific Reports
Multidisciplinary
2019English

Establishment of a First‑line Second‑line Treatment Model for Human Pulmonary Adenocarcinoma

Oncology Letters
Cancer ResearchOncology
2016English

Prolonged Response to First-Line Erlotinib for Advanced Lung Adenocarcinoma

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2008English

P068 the Geriatric Nutritional Risk Index Predicts the Overall Survival in Geriatric Patients With Metastatic Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

An Evaluation of the Impact of Missing Deaths on Overall Survival Analyses of Advanced Non–small Cell Lung Cancer Patients Conducted in an Electronic Health Records Database

Pharmacoepidemiology and Drug Safety
EpidemiologyPharmacology
2019English

A Five‑long Non‑coding RNA Signature With the Ability to Predict Overall Survival of Patients With Lung Adenocarcinoma

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

Prm256 - Adjustment for the Impact of Subsequent Therapies Not Available in Uk on Overall Survival (Os) in Castor Trial: A Subgroup Analysis in Second-Line (2l) Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy